Concord Wealth Partners Johnson & Johnson Transaction History

Concord Wealth Partners

$673 Million
Q2 2025

A detailed history of Concord Wealth Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Concord Wealth Partners holds 20,845 shares of JNJ stock, worth $3.46 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

20,845

Previous 23,061 9.61%

Holding current value

$3.46 Million

Previous $3.82 Million 16.74%

% of portfolio

0.47%

Previous 0.64%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	SELL	$146.36 - $159.82 $324,333 - $354,161	-2,216 Reduced 9.61%	20,845 $3.18 Million
Q1 2025 May 02, 2025	SELL	$142.06 - $167.7 $22,019 - $25,993	-155 Reduced 0.67%	23,061 $3.82 Million
Q4 2024 Jan 23, 2025	SELL	$143.34 - $165.86 $505,130 - $584,490	-3,524 Reduced 13.18%	23,216 $3.36 Million
Q3 2024 Oct 24, 2024	BUY	$145.48 - $167.38 $65,320 - $75,153	449 Added 1.71%	26,740 $4.33 Million
Q2 2024 Jul 31, 2024	SELL	$144.38 - $157.78 $167,913 - $183,498	-1,163 Reduced 4.24%	26,291 $3.84 Million
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $355,764 - $373,000	2,292 Added 9.11%	27,454 $4.34 Million
Q4 2023 Apr 30, 2024	BUY	$145.6 - $158.88 $601,473 - $656,333	4,131 Added 19.64%	25,162 $3.94 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $601,473 - $656,333	4,131 Added 19.64%	25,162 $3.94 Million
Q3 2023 Apr 30, 2024	SELL	$155.75 - $174.48 $643,403 - $720,776	-4,131 Reduced 16.42%	21,031 $3.28 Million
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $307,294 - $344,249	1,973 Added 10.35%	21,031 $3.28 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $929,032 - $999,816	6,019 Added 46.16%	19,058 $3.15 Million
Q1 2023 Apr 26, 2023	BUY	$151.05 - $180.26 $706,762 - $843,436	4,679 Added 55.97%	13,039 $2.02 Million
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $457,210 - $513,120	-2,854 Reduced 25.45%	8,360 $1.48 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $55,497 - $61,754	-344 Reduced 2.98%	11,214 $1.83 Million
Q2 2022 Aug 04, 2022	SELL	$168.19 - $186.01 $62,062 - $68,637	-369 Reduced 3.09%	11,558 $2.05 Million
Q1 2022 Apr 20, 2022	BUY	$158.14 - $179.59 $93,144 - $105,778	589 Added 5.19%	11,927 $2.11 Million
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $1.1 Million - $1.22 Million	7,075 Added 165.96%	11,338 $1.94 Million
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $861,441 - $957,292	-5,334 Reduced 55.58%	4,263 $688,000
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $128,062 - $137,369	803 Added 9.13%	9,597 $1.58 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $696,162 - $775,343	4,548 Added 107.11%	8,794 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $582,169 - $668,235	4,246 New	4,246 $668,000

Others Institutions Holding JNJ

# of Institutions

4,635

Shares Held

1.73B

Call Options Held

25.1M

Put Options Held

15.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $435B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Johnson & Johnson Transaction History